Session

Conventional therapy for IBD: Room for improvement

CORTICOSTEROID DOSING IN PEDIATRIC ACUTE SEVERE ULCERATIVE COLITIS: A MULTICENTER PROPENSITY SCORE STUDY

Marcus Auth, Tali Bdolah, Eyal Shteyer, David Mack, Jeffrey S Hyams, Neal Leleiko, Anne Griffiths, Dan Turner

DIFFERENT PROFILE OF EFFICACY OF THIOPURINES IN ULCERATIVE COLITIS AND CROHN’S DISEASE

Anna Testa, Antonio Rispo, Matilde Rea, Giovanni De Palma, Maria Diaferia, Dario Musto, Francesca Sasso, Nicola Caporaso

PRE-TREATMENT DIFFERENTIAL MICRORNA EXPRESSION PROFILE IN ULCERATIVE COLITIS PATIENTS ACCORDING TO THEIR RESPONSE TO CORTICOSTEROIDS.

Juan Enrique Naves, Josep Mañé, Miriam Mañosa Ciria, Ines Moret Tatay, Belen Beltran, EDUARD CABRE, Eugeni Domenech Morral

RAC1 POLYMORPHISMS AND THIOPURINE EFFICACY IN CHILDREN WITH INFLAMMATORY BOWEL DISEASE

Raffi Tzion, Oren Ledder, Paul Renbaum, Raphael Mevorach, Nurit Algur, Reeval Segel, Amir Karban, Eduard Koifman, Edna Efrati, Aleixo Muise, Dan Turner

RANDOMIZED CONTROLLED TRIAL COMPARING THE EFFICACY OF MEASALAMINE AND ORAL STEROIDS IN PATIENTS WITH MODERATELY ACTIVE ULCERATIVE COLITIS

Amit Raj, Yalaka Reddy, Chetana Vaishnavi, Kaushal K Prasad, Manik Thakur, Pradeep Kumar Siddappa, Kartar Singh, Rakesh Kochhar

ST10, A NOVEL ORAL FERRIC IRON, IS AN EFFECTIVE AND WELL-TOLERATED TREATMENT FOR IRON DEFICIENCY ANAEMIA IN IBD PATIENTS WHO FAIL TO RESPOND OR TOLERATE ORAL FERROUS PREPARATIONS: RESULTS FROM THE PHASE 3 STUDY PROGRAM

Christoph Gasché, Zsolt Tulassay, Andreas Stallmach, Julian Howell

Item 1 - 6 / 6
1